Nov 2, 2005 – Sydney, Australia — Novotech, Australia’s leading contract research organization (CRO), today announced that it has been awarded an “Highly Commended’ accolade in the prestigious NWS Premier’s 2005 Exporter of the Year Awards. Novotech CEO Alek Safarian, who attended the award’s ceremony, said he was very pleased to represent... Read more
November 2nd, 2005
Novotech Receives “Highly Commended” in NSW Premier’s 2005
September 9th, 2005
Novotech CEO invited to chair clinical trials
Sept 9, 2005 – London, UK — Novotech, the largest Australian full-service contract research organization (CRO) – with offices also in the UK and USA- , has accepted the London based Pharmaceutical & Biotech Outsourcing Research & Development Expo & Conference’s [PABORD] invitation for Novotech CEO Alek Safarian to chair the... Read more
June 22nd, 2005
Novotech launches innovative clinical trials risk
June 22, 2005 – Philadelphia, PA — Novotech, Australia’s largest contract research organization (CRO), today announced the launch of its Risk Sharing offering which guarantees massive savings on clinical trial costs for US firms in return for drug license rights in Australia and New Zealand. Novotech, which was this year awarded the prestigious... Read more
April 4th, 2005
Novotech, Quintiles and Pharma firms debate pros and cons
April 4, 2005 – Dallas, Texas — Novotech, Australia’s leading contract research organization (CRO), today announced that Novotech CEO Alek Safarian will debate the pros and cons of outsourcing globally at the 14th Annual Partnership with CROs and other Outsourcing Providers (April 4-6 Dallas). Other panelists include executives from pharma... Read more
March 17th, 2005
IDC/LSI Report identifies Australia as a key region
March 17, 2005 – Sydney, Australia — Novotech, Australia’s leading contract research organization (CRO), said premier market intelligence firm Life Science Insights (LSI), part of the IDC group, had identified Australia as a prime site for CRO outsourcing following a briefing with Novotech in California recently. Alek Safarian, Novotech CEO,... Read more
March 14th, 2005
Novotech to present benefits of outsourcing clinical
March 14, 2005 – Boston, MA — Novotech, Australia’s leading contract research organization (CRO), CEO Alek Safarian has been invited to present Australia’s outstanding clinical trials capabilities at the inaugural Sachs Bloomberg CRO Partnering Forum in Boston (March 15, 2005). In the past three years, Novotech has worked with more than... Read more
